Consistently, the number of cells in S phase was increased (P < 0.0001), which suggested that SATB1 promoted quiescence of AML cells while knockdown of SATB1 enhanced cell activation (Fig. 2e, f). This evidence concerns the gene SATB1 and acute myeloid leukemia.